Myomo (MYO) Cash & Equivalents (2016 - 2025)

Myomo has reported Cash & Equivalents for 10 years, with the latest figure at $14.1 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents fell 42.89% year-over-year to $14.1 million; the trailing twelve-month figure through Dec 2025 stood at $14.1 million (down 42.89% YoY), and the FY2025 full-year result was $14.1 million, down 42.89% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $14.1 million, up from $12.6 million in the prior quarter.
• The five-year high for Cash & Equivalents was $24.7 million in Q4 2024, with the low at $5.3 million in Q4 2022.
• Historically, Cash & Equivalents has averaged $11.6 million across 5 years, with a median of $11.4 million in 2022.
• Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 65.56% — and 2025, when it soared 271.11%.
• Myomo's Cash & Equivalents stood at $15.5 million in 2021, then plunged by 65.56% to $5.3 million in 2022, then climbed by 28.53% to $6.9 million in 2023, then jumped by 260.16% to $24.7 million in 2024, then sank by 42.89% to $14.1 million in 2025.
• The last three Cash & Equivalents figures came in at $14.1 million (Q4 2025), $12.6 million (Q3 2025), and $14.6 million (Q2 2025), per Business Quant data.